Assessment of Zinc Absorption From a Phytic Acid Rich Complementary Food

This study is currently recruiting participants.

Verified June 2012 by Swiss Federal Institute of Technology

Sponsor:

Information provided by (Responsible Party):

Prof. Michael B. Zimmermann, Swiss Federal Institute of Technology

ClinicalTrials.gov Identifier:

NCT01506648

First received: January 9, 2012

Last updated: June 29, 2012

Last verified: June 2012

History of Changes

Tracking Information
First Received Date ^ICMJE	January 9, 2012
Last Updated Date	June 29, 2012
Start Date ^ICMJE	January 2011
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT01506648 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Assessment of Zinc Absorption From a Phytic Acid Rich Complementary Food
Official Title ^ICMJE	Assessment of Zinc Absorption From a Phytic Acid Rich Complementary Food, Consumed by Young Children Immediately After the Addition of the Enzyme Phytase. A Randomized Single Blind Study
Brief Summary	Assessment of zinc absorption from a phytic acid rich complementary food, consumed by young children immediately after the addition of the enzyme phytase. A randomized single blind study
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Not Provided
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Probability Sample
Study Population	Study not related to a disease. Nutrition study without drug drug administration. Assessment of zinc absorption from a phytic acid rich complementary food, consumed by young children immediately after the addition of the enzyme phytase. A randomized single blind study
Condition ^ICMJE	Study Not Related to a Disease. Nutrition Study Without Drug Administration.
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Recruiting
Estimated Enrollment ^ICMJE	40
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: 12-24 month old Male of female Height and weight between -2.0 SD and +2.0 SD with respect to WHO child growth standards. No mineral and vitamin supplements 2 weeks prior to the study and during the whole duration of the study Exclusion Criteria: Body temperature ≥ 37.5°C Hemoglobin ≤ 7g/dL Positive RDT test Any metabolic, gastrointestinal or chronic disease (according to the statement of the subject's parent) known chronic diseases at the gastrointestinal tract) Long term mediation (that may affect zinc metabolism) during the whole study to interact with zinc metabolism (such as kidney diseases or
Gender	Both
Ages	12 Months to 24 Months
Accepts Healthy Volunteers	Yes
Contacts ^ICMJE	Not Provided
Location Countries ^ICMJE	Burkina Faso

Administrative Information
NCT Number ^ICMJE	NCT01506648
Other Study ID Numbers ^ICMJE	INSTAPA-FP7-211484
Has Data Monitoring Committee	Not Provided
Responsible Party	Prof. Michael B. Zimmermann, Swiss Federal Institute of Technology
Study Sponsor ^ICMJE	Swiss Federal Institute of Technology
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Swiss Federal Institute of Technology
Verification Date	June 2012
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top